Outset Medical ROA 2019-2025 | OM
Current and historical return on assets (ROA) values for Outset Medical (OM) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Outset Medical ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $-0.09B | $0.28B | -31.15% |
| 2025-06-30 | $-0.10B | $0.29B | -34.17% |
| 2025-03-31 | $-0.11B | $0.30B | -38.48% |
| 2024-12-31 | $-0.13B | $0.28B | -41.63% |
| 2024-09-30 | $-0.14B | $0.29B | -44.48% |
| 2024-06-30 | $-0.16B | $0.32B | -49.57% |
| 2024-03-31 | $-0.17B | $0.35B | -51.92% |
| 2023-12-31 | $-0.17B | $0.31B | -52.46% |
| 2023-09-30 | $-0.18B | $0.31B | -49.82% |
| 2023-06-30 | $-0.17B | $0.33B | -46.48% |
| 2023-03-31 | $-0.17B | $0.36B | -44.44% |
| 2022-12-31 | $-0.16B | $0.40B | -40.78% |
| 2022-09-30 | $-0.16B | $0.37B | -39.23% |
| 2022-06-30 | $-0.15B | $0.40B | -34.06% |
| 2022-03-31 | $-0.14B | $0.43B | -29.22% |
| 2021-12-31 | $-0.13B | $0.46B | -28.52% |
| 2021-09-30 | $-0.10B | $0.49B | -23.40% |
| 2021-06-30 | $-0.12B | $0.51B | -27.06% |
| 2021-03-31 | $-0.11B | $0.38B | -37.36% |
| 2020-12-31 | $-0.08B | $0.40B | -38.55% |
| 2020-06-30 | $-0.04B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.113B | $0.114B |
| Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $49.025B | 59.82 |
| Tempus AI (TEM) | United States | $12.432B | 0.00 |
| Doximity (DOCS) | United States | $9.874B | 40.87 |
| Hims & Hers Health (HIMS) | United States | $9.049B | 73.61 |
| IRhythm Technologies (IRTC) | United States | $5.681B | 0.00 |
| Hinge Health (HNGE) | United States | $3.475B | 0.00 |
| Privia Health (PRVA) | United States | $2.991B | 187.08 |
| Heartflow (HTFL) | United States | $2.850B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.632B | 43.55 |
| 10x Genomics (TXG) | United States | $2.065B | 0.00 |
| Enovis (ENOV) | United States | $1.802B | 9.46 |
| Omnicell (OMCL) | United States | $1.665B | 34.05 |
| Azenta (AZTA) | United States | $1.405B | 61.32 |
| Phreesia (PHR) | United States | $1.363B | 0.00 |
| Schrodinger (SDGR) | United States | $1.347B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.307B | 0.00 |
| Claritev (CTEV) | United States | $0.943B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.877B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.621B | 0.00 |
| Evolent Health (EVH) | United States | $0.592B | 0.00 |
| Talkspace (TALK) | United States | $0.585B | 117.67 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.458B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.381B | 0.00 |
| Carlsmed (CARL) | United States | $0.324B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.312B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| CapsoVision (CV) | United States | $0.255B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.210B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.192B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.190B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.172B | 0.00 |
| CareCloud (CCLD) | United States | $0.140B | 7.70 |
| EUDA Health Holdings (EUDA) | Singapore | $0.116B | 0.00 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.054B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |